Patients with multidrug-resistant tuberculosis who received regimens containing high-dose isoniazid (INH) had similar time to culture conversion and treatment outcomes as patients who received regimens with bedaquiline. INH is an inexpensive and safe medication that may contribute additive efficacy in combination regimens.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512704 | PMC |
| http://dx.doi.org/10.1093/ofid/ofac440 | DOI Listing |
Publication Analysis
Top Keywords
time culture
8
culture conversion
8
high-dose isoniazid
8
received regimens
8
conversion bedaquiline
4
bedaquiline high-dose
4
isoniazid drug-resistant
4
drug-resistant tuberculosis
4
tuberculosis patients
4
patients multidrug-resistant
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!